Medical Training AIPharmacogenomics for Medication Decisions
You'll be able to interpret a pharmacogenomic test report and use it to guide drug selection and dosing adjustments.
What this track covers
This track covers how genetic variation affects drug metabolism and response, with emphasis on CYP450 enzyme phenotypes, star allele nomenclature, and reading PGx lab reports. It applies these concepts to real prescribing decisions across cardiology, psychiatry, pain management, and oncology.
What you will practice
- Translate a star allele genotype into a predicted metabolizer phenotype
- Identify which drug-gene pairs have actionable prescribing guidance
- Adjust a medication plan when a PGx report flags a poor or rapid metabolizer
- Choose an alternative agent when a gene-drug interaction raises adverse event risk
- Counsel a patient on what their PGx result does and doesn't mean for future prescriptions
Simulator scenario
A patient starting a new psychiatric medication returns with a pharmacogenomic panel showing a CYP2D6 variant, and the clinician must decide whether and how to adjust the regimen.
Board question topics
- CYP450 metabolizer phenotype classification
- Interpreting star allele nomenclature on lab reports
- Drug-gene pairs with actionable dosing guidance
- PGx applications in psychiatry and pain management
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free